Bronte Capital Management Pty Ltd.
13F Reported Value
ⓘ$931.1M
incl. option notional
Equity Holdings
ⓘ$888.3M
Option Notional
ⓘ$42.8M
$0 puts / $42.8M calls
Holdings
57
Latest Filing
2026-06-30
Filing Quarter
Q2 2026
Portfolio Overview
Bronte Capital Management Pty Ltd. disclosed 57 positions worth $931.1M in its Form 13F-HR for Q2 2026 — $888.3M in common stock plus $42.8M of put/call option positions (reported at underlying notional value, not premium at risk), led by $GOOG (Alphabet Inc.) at 12.3% of the equity portfolio, followed by $REGN and $IBKR. During the quarter the fund opened 14 new positions and exited 11 — including a new stake in $RVMD and a full exit from $NKTR. The portfolio is most concentrated in Financials (24.1% of disclosed assets). All figures are sourced directly from Bronte Capital Management Pty Ltd.’s Form 13F-HR filing with the SEC under CIK 1471085.
AI Fund Analysis
Stable
Sector Allocation
AUM History
Top Equity Holdings by Value
Option Positions
13F rules report options at the value of the underlying shares (notional) — not the premium paid or capital at risk. Shown separately from the equity sleeve above.
Quarterly Activity — Q2 2026
Click any card to unlockTop Holdings
- 78.2#57
Quality
$109.1M305,165 sh - 71.0#201
Quality
$101.4M162,618 sh - 77.0#76
Quality
$76.9M883,526 sh VISA INC-CLASS A SHARES - COM
—Quality
$75.5M219,914 sh- 73.8
Quality
$73.0M145,847 sh - 68.7
Quality
$62.3M261,433 sh - 75.9
Quality
$54.3M300,176 sh - 71.0
Quality
$42.8M68,600 sh - 47.2
Quality
$38.7M456,656 sh - 62.4
Quality
$34.8M173,523 sh
| Company | Quality | Value | Shares |
|---|---|---|---|
 Alphabet Inc.$GOOG | 78.2#57 | $109.1M | 305,165 |
 REGENERON PHARMACEUTICALS, INC.$REGN | 71.0#201 | $101.4M | 162,618 |
 Interactive Brokers Group, Inc.$IBKR | 77.0#76 | $76.9M | 883,526 |
| VISA INC-CLASS A SHARES - COM | — | $75.5M | 219,914 |
 BERKSHIRE HATHAWAY INC$BRK.B | 73.8 | $73.0M | 145,847 |
 AMAZON COM INC$AMZN | 68.7 | $62.3M | 261,433 |
 Philip Morris International Inc.$PM | 75.9 | $54.3M | 300,176 |
| REGENERON PHARMACEUTICALS, INC.$REGNCALL | 71.0 | $42.8M | 68,600 |
 Corteva, Inc.$CTVA | 47.2 | $38.7M | 456,656 |
 CAPITAL ONE FINANCIAL CORP$COF | 62.4 | $34.8M | 173,523 |
Unlock AI quality scores for every holding
32-signal composite ranking on each of Bronte Capital Management Pty Ltd.'s 57 positions.
Showing top 10 of 57 holdings.
Sector Allocation
Financials
$214.2M
Technology
$144.1M
Healthcare
$144.0M
Consumer Staples
$141.0M
Other
$108.2M
Consumer Discretionary
$78.7M
Communication Services
$34.7M
Materials
$20.5M
Full Holdings — Bronte Capital Management Pty Ltd. (Q2 2026)
All 57 disclosed positions from the latest Form 13F-HR, with quarter-over-quarter share changes and 13F Pro quality scores. Sourced from SEC EDGAR.
| # | Ticker | Company | Value | Weight | QoQ | Quality |
|---|---|---|---|---|---|---|
| 1 | $GOOG | Alphabet Inc. | $109.1M | 12.3% | -20% | 78.2 |
| 2 | $REGN | REGENERON PHARMACEUTICALS, INC. | $101.4M | 11.4% | -6% | 71 |
| 3 | $IBKR | Interactive Brokers Group, Inc. | $76.9M | 8.7% | -31% | 77 |
| 4 | — | VISA INC-CLASS A SHARES - COM | $75.5M | 8.5% | -8% | — |
| 5 | $BRK.B | BERKSHIRE HATHAWAY INC | $73.0M | 8.2% | -6% | 73.8 |
| 6 | $AMZN | AMAZON COM INC | $62.3M | 7.0% | -9% | 68.7 |
| 7 | $PM | Philip Morris International Inc. | $54.3M | 6.1% | -12% | 75.9 |
| 8 | $REGNCALL | REGENERON PHARMACEUTICALS, INC. | $42.8M | — | +0% | 71 |
| 9 | $CTVA | Corteva, Inc. | $38.7M | 4.3% | -9% | 47.2 |
| 10 | $COF | CAPITAL ONE FINANCIAL CORP | $34.8M | 3.9% | -7% | 62.4 |
| 11 |  $DIS | Walt Disney Co | $34.7M | 3.9% | +94% | 60.1 |
| 12 |  $FCNCA | FIRST CITIZENS BANCSHARES INC /DE/ | $29.5M | 3.3% | -14% | 52.9 |
| 13 |  $TBBB | BBB FOODS INC | $22.2M | 2.5% | +9% | — |
| 14 |  $AUR | Aurora Innovation, Inc. | $14.9M | 1.7% | -6% | 11.8 |
| 15 | — | VANECK ETF TRUST - GOLD MINERS ETF | $14.5M | 1.6% | -8% | — |
| 16 |  $SHC | Sotera Health Co | $14.1M | 1.6% | -6% | 64.4 |
| 17 |  $NKTR | NEKTAR THERAPEUTICS | $13.9M | 1.6% | +0% | 9.7 |
| 18 |  $GHC | Graham Holdings Co | $13.1M | 1.5% | -10% | 55.9 |
| 19 | — | ISHARES TR - ISHARES BIOTECH | $12.5M | 1.4% | -5% | — |
| 20 |  $BF-A | BROWN FORMAN CORP | $12.4M | 1.4% | NEW | 56.6 |
| 21 |  $ALNY | ALNYLAM PHARMACEUTICALS, INC. | $10.7M | 1.2% | -5% | 71.4 |
| 22 |  $SQM | CHEMICAL & MINING CO OF CHILE INC | $8.6M | 1.0% | -5% | — |
| 23 |  $GLBE | Global-E Online Ltd. | $7.9M | 0.9% | +7% | — |
| 24 |  $NEM | NEWMONT Corp /DE/ | $6.5M | 0.7% | -8% | 86.8 |
| 25 |  $B | BARRICK MINING CORP | $5.4M | 0.6% | -8% | 69.6 |
| 26 |  $RAMP | LiveRamp Holdings, Inc. | $4.8M | 0.5% | -43% | 61.3 |
| 27 |  $HLF | HERBALIFE LTD. | $4.3M | 0.5% | -66% | — |
| 28 |  $RVMD | Revolution Medicines, Inc. | $3.5M | 0.4% | NEW | — |
| 29 |  $TPB | Turning Point Brands, Inc. | $3.5M | 0.4% | -5% | 51.8 |
| 30 | — | ISHARES TR - CORE S&P SCP ETF | $3.4M | 0.4% | NEW | — |
| 31 |  $BBWI | Bath & Body Works, Inc. | $3.3M | 0.4% | -8% | 69.4 |
| 32 |  $MDLZ | Mondelez International, Inc. | $3.1M | 0.3% | -5% | 56.4 |
| 33 |  $RSKD | RISKIFIED LTD. | $3.0M | 0.3% | +20% | — |
| 34 | $BF-A | BROWN FORMAN CORP | $2.6M | 0.3% | -5% | 56.6 |
| 35 |  $TYL | TYLER TECHNOLOGIES INC | $2.4M | 0.3% | NEW | 64.3 |
| 36 | — | VANECK ETF TRUST - JUNIOR GOLD MINE | $2.4M | 0.3% | -8% | — |
| 37 |  $PCTY | Paylocity Holding Corp | $1.9M | 0.2% | -51% | 66.8 |
| 38 |  $NICE | NICE Ltd. | $1.5M | 0.2% | -4% | — |
| 39 |  $OLED | UNIVERSAL DISPLAY CORP \PA\ | $889,193 | 0.1% | -8% | 58.7 |
| 40 |  $VRSK | Verisk Analytics, Inc. | $481,499 | 0.1% | -8% | 71.2 |
| 41 |  $ENVX | Enovix Corp | $92,900 | 0.0% | +262% | 26.5 |
| 42 |  $TMCI | TREACE MEDICAL CONCEPTS, INC. | $61,996 | 0.0% | NEW | 25.6 |
| 43 |  $FATE | FATE THERAPEUTICS INC | $58,698 | 0.0% | -5% | 9.2 |
| 44 |  $ANTX | AN2 Therapeutics, Inc. | $52,732 | 0.0% | NEW | — |
| 45 |  $CCCC | C4 Therapeutics, Inc. | $48,330 | 0.0% | +3% | 18.2 |
| 46 |  $ALXO | ALX ONCOLOGY HOLDINGS INC | $37,457 | 0.0% | NEW | — |
| 47 |  $BLND | Blend Labs, Inc. | $32,912 | 0.0% | NEW | 39.5 |
| 48 |  $PEPG | PepGen Inc. | $31,997 | 0.0% | NEW | — |
| 49 |  $CMRC | Commerce.com, Inc. | $30,423 | 0.0% | NEW | 43.3 |
| 50 |  $PACB | PACIFIC BIOSCIENCES OF CALIFORNIA, INC. | $30,040 | 0.0% | NEW | 17.1 |
| 51 |  $ABOS | Acumen Pharmaceuticals, Inc. | $28,612 | 0.0% | NEW | — |
| 52 |  $SEER | Seer, Inc. | $25,081 | 0.0% | NEW | 14 |
| 53 |  $ALEC | Alector, Inc. | $23,634 | 0.0% | -39% | 10.9 |
| 54 |  $NBP | NovaBridge Biosciences | $21,824 | 0.0% | NEW | — |
| 55 |  $CHRS | Coherus Oncology, Inc. | $21,367 | 0.0% | -21% | 5 |
| 56 |  $MIST | Milestone Pharmaceuticals Inc. | $19,283 | 0.0% | +38% | — |
| 57 |  $GOSS | Gossamer Bio, Inc. | $11,152 | 0.0% | NEW | 8.2 |
New Positions (14)
$RVMD Revolution Medicines, Inc.$3.5M$TYL TYLER TECHNOLOGIES INC$2.4M$TMCI TREACE MEDICAL CONCEPTS, INC.$61,996$ANTX AN2 Therapeutics, Inc.$52,732$ALXO ALX ONCOLOGY HOLDINGS INC$37,457$BLND Blend Labs, Inc.$32,912$PEPG PepGen Inc.$31,997$CMRC Commerce.com, Inc.$30,423$PACB PACIFIC BIOSCIENCES OF CALIFORNIA, INC.$30,040$ABOS Acumen Pharmaceuticals, Inc.$28,612$SEER Seer, Inc.$25,081$NBP NovaBridge Biosciences$21,824$GOSS Gossamer Bio, Inc.$11,152Exited Positions (11)
Browse Top Institutional Investors
13F Pro tracks 8,700+ institutional investors filing 13F reports with the SEC.
to search all 8,700+ institutional filers.
Available Analysis
13F Pro tracks comprehensive institutional data for Bronte Capital Management Pty Ltd. including:
Track Bronte Capital Management Pty Ltd.'s Full Portfolio
See every holding, quarter-over-quarter changes, sector allocation, and accumulation patterns for Bronte Capital Management Pty Ltd. and 8,700+ other institutional investors.
Free tier includes full 13F search and fund profiles. Pro starts at $6.67/mo (billed annually).
AI-Powered Hedge Fund Analysis: Bronte Capital Management Pty Ltd.
13F Pro is an AI hedge fund tracker and stock research platform. For Bronte Capital Management Pty Ltd. (SEC CIK: 1471085), the platform ingests every quarterly Form 13F filing and applies AI-powered analysis on top — 10 specialized AI analysts (value, growth, momentum, macro, activist, and more) debate the fund's top positions and publish AI-generated analysis with cited SEC sources.
Every holding in Bronte Capital Management Pty Ltd.'s portfolio is scored on a 32-signal AI quality ranking (ROIC, FCF margin, revenue growth, institutional flow, earnings quality, shareholder dilution, and more). Track accumulation and distribution quarter over quarter, identify conviction positions, and see AI stock analysis for each position — alongside 8,700+ other institutional filers and 2,800+ AI-ranked companies.